NCT06425380

Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 11 (estimated)
• Sponsor: Mayo Clinic · Academic / Other
• Sex: All
• Age: 18 Years – 99 Years
• Healthy volunteers: Not accepted

Summary

This research is studying how a food product (resistant potato starch) which is a dietary supplement made from potato starch affects the gut bacteria of people with cirrhosis and hepatic encephalopathy. The researchers in this study want to understand how potato starch works in the subject's body and how the body will react to it. Along with taking the study product participants health-related information and stool will be collected for this research study.

Conditions

• Hepatic Encephalopathy
• Cirrhosis

Interventions

Type	Name	Description
OTHER	Resistant Potato Starch	Participants will receive 4 weeks of resistant potato starch 20 grams (g) twice daily. Bob's Red Mill® potato starch will be used. Every patient will receive the same dose and there are no dose titrations.

Timeline

• Start date: 2024-07-12
• Primary completion: 2027-01-28
• Completion: 2027-01-28
• First posted: 2024-05-22
• Last updated: 2026-01-30

Locations

2 sites across 1 country: United States